Literature DB >> 12573300

Effects of acute and chronic administration of selective monoamine re-uptake inhibitors in the rat forced swim test.

P Kelliher1, J P Kelly, B E Leonard, C Sánchez.   

Abstract

The rat forced swim test (FST) is a model that is used extensively as a screening test for antidepressant activity. It has previously been reported that thorough analysis of behaviour in this model reveals two distinct types of active response - climbing and swimming - and that these are separately evoked by re-uptake inhibitors selective for noradrenaline (NA) and serotonin (5-HT), respectively. In the present study, utilising re-uptake inhibitors selective for NA, talsupram, and 5-HT, 5-chloro-1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)- phthalan (Lu 10-134-C), we examined if this scoring technique could detect the antidepressant potential of a selective serotonin re-uptake inhibitor (SSRI), and whether re-uptake inhibitors selective for distinct monoamine systems induce exclusive behavioural responses. We also analysed if chronic antidepressant administration for three weeks was more effective than acute treatment. We found Lu 10-134-C (40 mg/kg; PO) to be behaviourally active in this paradigm. Although treatment with talsupram (40 mg/kg; PO) resulted solely in climbing behaviour, Lu 10-134-C induced both climbing and swimming behaviour. However, chronic pre-treatment with either re-uptake inhibitor (20 mg/kg; twice daily; PO) failed to augment the response observed with acute treatment. Similarly, chronic administration of either compound was without effect on the basal, or stress-induced, serum corticosterone concentrations or anterior pituitary (AP) preproopiomelanocorticotropin (POMC) mRNA expression. These results suggest that selective monoamine re-uptake inhibition produces distinct, but not necessarily exclusive, behavioural responses in the forced swim test.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12573300     DOI: 10.1016/s0306-4530(02)00026-4

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  3 in total

1.  Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment.

Authors:  John F Cryan; Michelle E Page; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

Review 2.  Encore: Behavioural animal models of stress, depression and mood disorders.

Authors:  Aleksa Petković; Dipesh Chaudhury
Journal:  Front Behav Neurosci       Date:  2022-08-08       Impact factor: 3.617

3.  Influence of sex and corticotropin-releasing factor pathways as determinants in serotonin sensitivity.

Authors:  Jonathan G McEuen; Katharine A Semsar; Maria A Lim; Tracy L Bale
Journal:  Endocrinology       Date:  2009-04-02       Impact factor: 4.736

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.